These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31792860)

  • 1. Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty.
    Hollander MAG; Donohue JM; Stein BD; Krans EE; Jarlenski MP
    J Gen Intern Med; 2020 Aug; 35(8):2451-2458. PubMed ID: 31792860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
    Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
    PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical payments to physicians may increase prescribing for opioids.
    Nguyen TD; Bradford WD; Simon KI
    Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
    Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
    J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical opioid marketing and physician prescribing behavior.
    Beilfuss S; Linde S
    Health Econ; 2021 Dec; 30(12):3159-3185. PubMed ID: 34562329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' attitudes about gifts to physicians from pharmaceutical companies.
    Blake RL; Early EK
    J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing.
    Eisenberg MD; Stone EM; Pittell H; McGinty EE
    Health Aff (Millwood); 2020 Jun; 39(6):1002-1010. PubMed ID: 32479218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
    Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
    JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.
    Fleischman W; Agrawal S; King M; Venkatesh AK; Krumholz HM; McKee D; Brown D; Ross JS
    BMJ; 2016 Aug; 354():i4189. PubMed ID: 27540015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perceptions of physician acceptance of gifts from the pharmaceutical industry.
    Mainous AG; Hueston WJ; Rich EC
    Arch Fam Med; 1995 Apr; 4(4):335-9. PubMed ID: 7711920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.
    Qian J; Hansen RA; Surry D; Howard J; Kiptanui Z; Harris I
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):819-826. PubMed ID: 28485111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry gifts to physicians: patient beliefs and trust in physicians and the health care system.
    Grande D; Shea JA; Armstrong K
    J Gen Intern Med; 2012 Mar; 27(3):274-9. PubMed ID: 21671130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.